156 related articles for article (PubMed ID: 20739883)
1. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
[TBL] [Abstract][Full Text] [Related]
2. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H
Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia.
Meex SJ; van der Kallen CJ; van Greevenbroek MM; Eurlings PM; El Hasnaoui M; Evelo CT; Lindsey PJ; Luiken JJ; Glatz JF; de Bruin TW
FASEB J; 2005 Dec; 19(14):2063-5. PubMed ID: 16219805
[TBL] [Abstract][Full Text] [Related]
5. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
[TBL] [Abstract][Full Text] [Related]
6. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
7. Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia.
Brouwers MC; van der Kallen CJ; Schaper NC; van Greevenbroek MM; Stehouwer CD
Neth J Med; 2010 Apr; 68(4):163-7. PubMed ID: 20421657
[TBL] [Abstract][Full Text] [Related]
8. Relationship between familial combined hyperlipidemia and insulin resistance.
Jackuliaková D; Vaverková H; Karásek D
Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia.
Ayyobi AF; Brunzell JD
Am J Cardiol; 2003 Aug; 92(4A):27J-33J. PubMed ID: 12957324
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones.
Yki-Järvinen H
N Engl J Med; 2004 Sep; 351(11):1106-18. PubMed ID: 15356308
[No Abstract] [Full Text] [Related]
11. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
12. The genetic basis of obesity and type 2 diabetes: lessons from the new zealand obese mouse, a polygenic model of the metabolic syndrome.
Joost HG
Results Probl Cell Differ; 2010; 52():1-11. PubMed ID: 20865367
[TBL] [Abstract][Full Text] [Related]
13. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus.
van der Kallen CJ; Voors-Pette C; Bouwman FG; Keizer HA; Lu JY; van de Hulst RR; Bianchi R; Janssen MJ; Keulen ET; Boeckx WD; Rotter JI; de Bruin TW
Atherosclerosis; 2002 Oct; 164(2):337-46. PubMed ID: 12204806
[TBL] [Abstract][Full Text] [Related]
14. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC; Lusis AJ; Pajukanta P
Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
[TBL] [Abstract][Full Text] [Related]
15. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
16. [Disorder of lipid metabolism in visceral fat syndrome--relation to familial combined hyperlipidemia].
Ishigami M; Nakamura T; Matsuzawa Y
Nihon Rinsho; 2002 May; 60(5):868-74. PubMed ID: 12029987
[TBL] [Abstract][Full Text] [Related]
17. [Renaissance of metformin].
Sieradzki J
Przegl Lek; 1999; 56(5):331-4. PubMed ID: 10554568
[TBL] [Abstract][Full Text] [Related]
18. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome and nonalcoholic fatty liver disease.
Collantes RS; Ong JP; Younossi ZM
Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
